Back

uORF-targeting steric block antisense oligonucleotides do not reproducibly activate RNASEH1 expression

Ahlskog, N.; Svrzikapa, N.; Abuhamdah, R.; Kye, M.; Jad, Y.; Feng, N.; Hanson, B.; Wood, M.; Roberts, T. C.

2024-06-14 biochemistry
10.1101/2024.06.14.598998 bioRxiv
Show abstract

Upstream open reading frames (uORFs) are cis-regulatory motifs that are predicted to occur in the 5' untranslated region (UTR) of the majority of human protein-coding transcripts. uORFs are typically associated with repression of the downstream primary open reading frame (pORF) at either the level of translation, or by promoting mRNA turnover via the nonsense-mediated decay pathway. Interference with uORF activity provides a potential mechanism for targeted upregulation of the expression of specific transcripts. It was recently reported that steric block antisense oligonucleotides (ASOs) can bind to and mask uORF start codons in order to inhibit translation initiation, and thereby disrupt uORF-mediated gene regulation. Given the relative maturity of the oligonucleotide field, such a uORF blocking mechanism might have widespread therapeutic utility. Here, we re-synthesised three of the most potent ASOs targeting the RNASEH1 uORF described in the study by Liang et al. and investigated their potential for RNASEH1 protein upregulation. No upregulation (of endogenous or reporter protein expression) was observed with any of the oligonucleotides tested at doses ranging from 25 nM to 300 nM. Conversely, we observed downregulation of expression in some instances, consistent with well-established mechanisms of blocking ribosome procession. Experiments were performed using multiple transfection protocol setups, with care taken to replicate the conditions of the original study. Transfection efficiency was confirmed using a MALAT1-targeting gapmer ASO as a positive control. We conclude that previously-described RNASEH1 uORF-targeting steric block ASOs are incapable of upregulating pORF protein expression in our hands.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
Molecular Therapy Nucleic Acids
32 papers in training set
Top 0.1%
18.9%
2
RNA
169 papers in training set
Top 0.1%
12.5%
3
Nucleic Acids Research
1128 papers in training set
Top 2%
9.3%
4
Molecular Therapy - Nucleic Acids
24 papers in training set
Top 0.1%
6.9%
5
ACS Chemical Biology
150 papers in training set
Top 0.2%
6.9%
50% of probability mass above
6
Scientific Reports
3102 papers in training set
Top 27%
4.4%
7
PLOS ONE
4510 papers in training set
Top 38%
3.6%
8
NAR Molecular Medicine
18 papers in training set
Top 0.1%
3.1%
9
RSC Chemical Biology
32 papers in training set
Top 0.1%
2.8%
10
Biochemistry
130 papers in training set
Top 0.5%
2.5%
11
Cell Chemical Biology
81 papers in training set
Top 2%
1.7%
12
ACS Omega
90 papers in training set
Top 2%
1.7%
13
Journal of Biological Chemistry
641 papers in training set
Top 2%
1.7%
14
Molecular Therapy
71 papers in training set
Top 1%
1.7%
15
RNA Biology
70 papers in training set
Top 0.3%
1.3%
16
Nature Communications
4913 papers in training set
Top 54%
1.3%
17
iScience
1063 papers in training set
Top 26%
0.9%
18
ChemBioChem
50 papers in training set
Top 1%
0.8%
19
International Journal of Molecular Sciences
453 papers in training set
Top 14%
0.8%
20
ACS Bio & Med Chem Au
11 papers in training set
Top 0.1%
0.8%
21
Molecular Therapy - Methods & Clinical Development
38 papers in training set
Top 0.5%
0.8%
22
Life Science Alliance
263 papers in training set
Top 2%
0.7%
23
Molecular Pharmaceutics
16 papers in training set
Top 0.6%
0.7%
24
Protein Science
221 papers in training set
Top 2%
0.7%
25
Philosophical Transactions of the Royal Society B
51 papers in training set
Top 7%
0.5%
26
Cellular and Molecular Life Sciences
84 papers in training set
Top 1%
0.5%